Trial Profile
A study evaluating Platelet Reactivity in continuous-flow Left Ventricular Assist Device (CF-LVAD) Implantation patients treated with P2Y12 inhibitors: Clopidogrel (CLO), Prasugrel (PRA), or Ticagrelor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2017
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 19 Apr 2017 New trial record